BusinessVericel Announces FDA Approval of Epicel HDE SupplementBy Nasdaq OMXFeb 22, 2016, 1:30 PM UTC
BusinessProtalix BioTherapeutics to Participate in the SunTrust Robinson Humphrey Orphan Drug Day and the 12th Annual WORLDSymposium™ 2016By Nasdaq OMXFeb 22, 2016, 12:30 PM UTC
BusinessIntrommune Therapeutics to Present at New York Venture Capital Association 2016 Health & Bio Technology SummitBy Nasdaq OMXFeb 22, 2016, 12:15 PM UTC
BusinessCuris to Release Fourth Quarter and Year End 2015 Financial Results and Hold Conference Call on February 29, 2016By Nasdaq OMXFeb 22, 2016, 12:00 PM UTC
BusinessChromaDex Announces Commencement of an Obesity-Related Clinical Study of NIAGEN® in Collaboration With the University of Copenhagen and Aarhus UniversityBy Nasdaq OMXFeb 22, 2016, 11:30 AM UTC
BusinessAffimed to Speak at Symposium on Emerging Approaches in Cancer ImmunotherapyBy Nasdaq OMXFeb 22, 2016, 10:00 AM UTC
BusinessFate Therapeutics to Present Preclinical Data for ProTmune™ at 2016 BMT Tandem MeetingsBy Nasdaq OMXFeb 21, 2016, 1:01 PM UTC
BusinessCelldex Presents Preliminary Cohort Data from Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Harvest at the 2016 BMT Tandem MeetingBy Nasdaq OMXFeb 20, 2016, 1:00 PM UTC
